CXCR4 and lymphoma: Despite a plethora of evidence linking CXCR4 to the pathogenesis of CLL and DLBCL, it is unknown if and how enhancing CXCR4 pathway activity can alter the course of B-cell lymphoproliferation, and B-cell leukemia/ lymphoma development and progression.